Literature DB >> 19819904

Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase.

Ryo Takahashi1, Shota Nakamura, Takashi Nakazawa, Katsuhiko Minoura, Takuya Yoshida, Yoshinori Nishi, Yuji Kobayashi, Tadayasu Ohkubo.   

Abstract

Nicotinamide (NM) phosphoribosyltransferase (NMPRTase) catalyzes the reaction of NM and 5'-phosphoribosyl-1'-pyrophosphate (PRPP) to form NM mononucleotide (NMN) and pyrophosphate (PPi) in the pathway of NAD-biosynthesis. Monitoring the (1)H and (31)P NMR spectra of the reaction mixture, we found that this reaction is reversible as dictated by the equilibrium constant K = [NMN][PPi]/([NM][PRPP]) = 0.14, which agreed well with the ratio of second-order rate constants for forward and backward reactions, K = 0.16. The crystal structures of this enzyme in the free form and bound to NM and PRPP at the resolution of 2.0-2.2 A were essentially identical to that of the complex with NMN, except for some variations that could facilitate the substitution reaction by fixing the nucleophile and the leaving group for the requisite inversion of configuration at the C1' carbon of the ribose ring. In the active site near the C1' atom of the bound PRPP or NMN, there was neither negatively charged group nor waterproof environment necessary to support the feasibility of a ribo-oxocarbocation intermediate inherent in the S(N)1 mechanism. The structures and catalytic mechanism thus revealed are also discussed in connection with the multiple biological functions of NMPRTase.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819904     DOI: 10.1093/jb/mvp152

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

Review 1.  Phosphoribosyl Diphosphate (PRPP): Biosynthesis, Enzymology, Utilization, and Metabolic Significance.

Authors:  Bjarne Hove-Jensen; Kasper R Andersen; Mogens Kilstrup; Jan Martinussen; Robert L Switzer; Martin Willemoës
Journal:  Microbiol Mol Biol Rev       Date:  2016-12-28       Impact factor: 11.056

2.  Discovery of small-molecule activators of nicotinamide phosphoribosyltransferase (NAMPT) and their preclinical neuroprotective activity.

Authors:  Hong Yao; Minghui Liu; Leibo Wang; Yumeng Zu; Chou Wu; Chenyu Li; Ruoxi Zhang; Haigen Lu; Feifei Li; Shuang Xi; Shuangquan Chen; Xuanyu Gu; Tianya Liu; Jie Cai; Shirong Wang; Maojun Yang; Guo-Gang Xing; Wei Xiong; Lan Hua; Yefeng Tang; Gelin Wang
Journal:  Cell Res       Date:  2022-04-22       Impact factor: 46.297

3.  Inorganic pyrophosphatase defects lead to cell cycle arrest and autophagic cell death through NAD+ depletion in fermenting yeast.

Authors:  Gloria Serrano-Bueno; Agustín Hernández; Guillermo López-Lluch; José Román Pérez-Castiñeira; Plácido Navas; Aurelio Serrano
Journal:  J Biol Chem       Date:  2013-03-11       Impact factor: 5.157

4.  Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy.

Authors:  Peter M LoCoco; April L Risinger; Hudson R Smith; Teresa S Chavera; Kelly A Berg; William P Clarke
Journal:  Elife       Date:  2017-11-10       Impact factor: 8.140

5.  Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells.

Authors:  David Estoppey; Jeffrey W Hewett; Chantale T Guy; Edmund Harrington; Jason R Thomas; Markus Schirle; Rachel Cuttat; Annick Waldt; Bertran Gerrits; Zinger Yang; Sven Schuierer; Xuewen Pan; Kevin Xie; Walter Carbone; Judith Knehr; Alicia Lindeman; Carsten Russ; Elizabeth Frias; Gregory R Hoffman; Malini Varadarajan; Nadire Ramadan; John S Reece-Hoyes; Qiong Wang; Xin Chen; Gregory McAllister; Guglielmo Roma; Tewis Bouwmeester; Dominic Hoepfner
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

6.  Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level.

Authors:  Chenyang Ye; Lina Qi; Xiaofen Li; Ji Wang; Jiekai Yu; Biting Zhou; Cheng Guo; Jiani Chen; Shu Zheng
Journal:  Cell Commun Signal       Date:  2020-01-31       Impact factor: 5.712

Review 7.  Nicotinamide Adenine Dinucleotide (NAD) Metabolism as a Relevant Target in Cancer.

Authors:  Lola E Navas; Amancio Carnero
Journal:  Cells       Date:  2022-08-24       Impact factor: 7.666

8.  The evolutionary portrait of metazoan NAD salvage.

Authors:  João Carneiro; Sara Duarte-Pereira; Luísa Azevedo; L Filipe C Castro; Paulo Aguiar; Irina S Moreira; António Amorim; Raquel M Silva
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Structural basis for resistance to diverse classes of NAMPT inhibitors.

Authors:  Weiru Wang; Kristi Elkins; Angela Oh; Yen-Ching Ho; Jiansheng Wu; Hong Li; Yang Xiao; Mandy Kwong; Mary Coons; Bobby Brillantes; Eric Cheng; Lisa Crocker; Peter S Dragovich; Deepak Sampath; Xiaozhang Zheng; Kenneth W Bair; Thomas O'Brien; Lisa D Belmont
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

10.  NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples.

Authors:  Sara Duarte-Pereira; Sarah S Silva; Luísa Azevedo; Luísa Castro; António Amorim; Raquel M Silva
Journal:  Sci Rep       Date:  2014-09-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.